Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLYPSO: Early Intervention in Plaque Psoriasis with Bimekizumab
NCT06742333Phase 2Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jul 2025
- Primary completion
- Jul 2028
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bimekizumab in plaque psoriasis, sponsored by Centre Hospitalier Universitaire de Nice. Started Jul 2025; status: recruiting.
02
Drugs
bimekizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06742333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06742333.